Plain-English translation of NCT07324005 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Carpal tunnel syndrome happens when a nerve in your wrist gets squeezed, causing tingling, numbness, and pain in your hand. This trial is testing three different combinations of a newer, minimally invasive treatment: using ultrasound (sound wave imaging) to guide a needle that either releases tension on the ligament pressing the nerve, injects dextrose (a simple sugar water solution) around the nerve to reduce swelling, or does both. The goal is to find out which approach works best without the risks of traditional surgery.
Many people with carpal tunnel syndrome don't want surgery because of infection risk, scarring, and pain during recovery. This trial exists to see if these gentler needle-based techniques can give people relief while avoiding those surgical complications.
You likely qualify if…
You likely don't qualify if…
You will receive one treatment session guided by ultrasound imaging at the hospital. Depending on which group you are assigned to, you will receive either an injection of sugar water around your nerve, a needle release of the ligament with sugar water injection, or a combination of both techniques. The procedure takes place in an outpatient clinic, and you should be able to go home the same day.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Taiwan